missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18657575

CD8 Antibody (C8/468) - IHC-Prediluted, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-45323

Product Code. 18657575

  • 497.00 € / 7mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD8 Monoclonal antibody specifically detects CD8 in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD8
Monoclonal
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Immunohistochemistry, Immunohistochemistry (Paraffin)
C8/468
Immunohistochemistry, Immunohistochemistry-Paraffin 1:100 - 1:200
CD_antigen: CD8a, CD8, CD8 antigen, alpha polypeptide (p32), CD8A, CD8a molecule, LEU2, Leu2 T-lymphocyte antigen, MAL, OKT8 T-cell antigen, p32, T cell co-receptor, T8 T-cell antigen, T-cell antigen Leu2, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2
Human CD8 recombinant protein (Uniprot: P01732 )
7 mL
Adaptive Immunity, Cancer, Cytokine Research, Immunology, Innate Immunity, Signal Transduction, Stem Cell Markers
925
Store at 4°C.
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.